Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response
What to Expect in the First Few Weeks of GLP-1 Treatment During the initial weeks of GLP-1 therapy, patients commonly experience a reduction in appetite and changes in eating patterns , often before seeing significant changes on the scales or in blood glucose readings
How GLP-1 Works When you eat, L-cells in your small intestine release GLP-1 into your bloodstream
Tremfya (guselkumab) Disease area(s): Immunology Manufacturer(s): Johnson & Johnson 2024 Sales (USD): $3.67 billion Why it sold so well: J&Js IL-23 inhibitor Tremfya experienced significant sales growth last year with $3.67 billion in total sales, an increase of 16.6% from 2023
